Moderna, Biotechnology company

US biotechnology firm Moderna announced on Monday that its COVID-19 vaccine has demonstrated a 'neutralising impact' on coronavirus variants first found in the United Kingdom and South Africa.According to a news release by the firm, the two doses of the vaccine "is expected to be protective against emerging strains detected to date.""Results from in vitro neutralisation studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine (are) showing activity against emerging strains of SARS-CoV-2... Vaccination with the Moderna COVID-19 Vaccine produced neutralizing titers against all key emerging variants tested, including B.1.1.7 and B.1.351, first identified in the UK and Republic of South Africa, respectively. The study showed no significant impact on neutralising titers against the B.1.1.7 variant relative to prior variants," Moderna said.This study was conducted in collaboration with the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The manuscript has been submitted as a preprint to bioRxiv and will be submitted for peer-reviewed publication.The company is advancing an emerging variant booster candidate (mRNA-1273.351) against the variant first identified in South Africa."A six-fold reduction in neutralising titers was observed with the B.1.351 variant relative to prior variants. Despite this reduction, neutralising titer levels with B.1.351 remain above levels that are expected to be protective," it said.According to Sputnik, British Prime Minister Boris Johnson said the B.1.1.7 variant of the coronavirus, initially reported to be 50-70 percent more contagious, has been discovered and it is likely to be 30 percent deadlier.CNN reported that David Montefiori, a virologist at Duke University Medical Center, said while he's "cautiously optimistic" Moderna's vaccine will work well against this strain, he is still not sure."The efficacy might be reduced somewhat, but it may still be very effective," he said, as quoted by CNN and added, "Hopefully the vaccine will still be 70-80 per cent effective."The variant first identified in the UK has also appeared in more than 45 other countries, including 195 cases in the US. The variant first identified in South Africa has appeared in more than 20 other countries.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

ModernaFOLLOW

Moderna, Latest News

A day after COVID vaccine manufacturer Moderna allegedly refused to send vaccines directly to the Punjab government, Chief Minister Arvind Kejriwal on Monday informed that Pfizer and Moderna have refused to sell vaccines directly to the Delhi governm ...

Vaccination with a booster shot among as many people as possible is a good way to protect those most at risk against ever-emerging new coronavirus variants, Moderna CEO Stephane Bancel said on Sunday. ...

At least nine people have become new billionaires since the beginning of Covid pandemic, thanks to the excessive profits pharmaceutical corporations with monopolies on Covid vaccines are making, the People's Vaccine Alliance said on Thursday ahead of ...

US pharmaceutical company Moderna seeks to supply 3 billion vaccine doses against COVID-19 in 2022 instead of 1.4 billion, which is twice as many than planned, according to the company's statement, published on Thursday. ...

Researchers at Oxford University have found the risk of a rare type of blood clot is low overall, but higher for people who have been infected with Covid-19 than among people who've had the three vaccines authorized in the UK - those made by AstraZen ...

Moderna has begun testing its COVID-19 vaccine on children and infants between the ages of six months and 12 years old in a study, as the pharmaceutical company seeks to expand approval for its vaccine to children, the company said on Tuesday. ...

New York, March 16 Biotechnology company Moderna announced that the first participants have been dosed in the Phase ... ...

US biotechnology firm Moderna announced on Monday that its COVID-19 vaccine has demonstrated a 'neutralising impact' on coronavirus variants first found in the United Kingdom and South Africa. ...